Philips Launches Transcend Plus Cardiovascular Ultrasound with 26 FDA-Cleared AI Applications

Philips has launched Transcend Plus, the next generation of its EPIQ CVx and Affiniti CVx cardiovascular ultrasound systems, featuring significant advancements in image quality and artificial intelligence (AI). The system includes newly FDA-cleared 2D and 3D imaging enhancements and integrates 26 FDA-cleared AI applications, the most in the industry, designed to improve diagnostic confidence and streamline clinical workflows. Transcend Plus offers major improvements in sharpness, contrast, and detail, supporting superior visualization of cardiac anatomy and function even in complex cases, with tools like 2D Auto EF Advanced aiding accurate cardiac function assessment. The AI integration automates time-consuming measurements, reduces operator variability, and supports fast, confident decision-making across various cardiac care settings. Philips emphasizes that this release reinforces its leadership in cardiovascular ultrasound by empowering clinicians with AI-driven tools to enhance efficiency and patient care amid rising clinical complexity and staffing challenges. The system is currently being demonstrated at major cardiology conferences and is positioned as a transformative step in echocardiography innovation.